Study on efficacy of sage in the treatment of hyperlipidemic patients

Phase 3

• Conditions: Hyperlipidemia.; Hyperlipidemia, unspecified

• Registration Number: IRCT138805132288N1
• Lead Sponsor: Research Institute for Islamic and Complementary Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients aged 20 to 60 years, patients with serum cholesterol level above 240 mg/dl, patients with serum triglyceride level above 200 mg/dl, patients recently diagnosed as hyperlipidemic, literate patients.
Exclusion criteria: patients with serum cholesterol or triglyceride levels above 300 mg/dl, patients with cardiac, renal, hepatic, hematological diseases, hypothyroidism, diabetes, tachycardia, vertigo and seizure, patients with a history of gallstones or gall bladder surgery, patients using estrogen, steroid, beta-blocker and thiazide, pregnant women, women planning pregnancy, breast-feeding women.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease of the blood serum cholesterol level in patients. Timepoint: 1 month. Method of measurement: Medical laboratory (kit).;Decrease of the blood serum triglyceride level in patients. Timepoint: 1 month. Method of measurement: Medical laboratory (kit).

Secondary Outcome Measures

Name	Time	Method
Decrease of the blood serum LDL cholesterol level in patients. Timepoint: 1 month. Method of measurement: Medical laboratory (kit).;Dcrease of the blood serum VLDL lipoprotein level in patients. Timepoint: 1 month. Method of measurement: Medical laboratory (kit).;Increase of the blood serum HDL cholesterol level in patients. Timepoint: 1 month. Method of measurement: Medical laboratory (kit).